ライブラリ登録: Guest
Critical Reviews™ in Oncogenesis

年間 4 号発行

ISSN 印刷: 0893-9675

ISSN オンライン: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Oncogene-lnitiated Aberrant Signaling Engenders the Metastatic Phenotype: Synergistic Transcription Factor Interactions are Targets for Cancer Therapy

巻 7, 発行 3-4, 1996, pp. 261-291
DOI: 10.1615/CritRevOncog.v7.i3-4.70
Get accessGet access

要約

Certain p21GTPases (notably Ras) and some of their guanine nucleotide exchange factors (e.g., Ost, Dbl, Tiam) and downstream mediators (e.g., Raf, Мус) have the potential to promote the development of malignancies because they can enhance the transcription of genes that foster the tumorigenic and metastatic phenotype. Among these are genes that stimulate cell proliferation, confer immortality, and facilitate the invasion of normal tissues. Oncogenes upstream of Ras—cell surface receptors such as ErbB2/Neu, Met, or Trk (and their ligands), and nonreceptor cytoplasmic protein tyrosine kinases such as Src and Abl—not only can act through Ras but also contribute additional signals. This review presents a synopsis of our understanding of signaling pathways controlled by the p21GTPases, with a focus on transcription factors regulated by the pathways. Mutations in one or more of the elements in these signaling pathways are invariably found in cancer cells. Crosstalk among the pathways may explain how some forms of stress can contribute to the development of a malignancy. Abnormal signaling leads to modified cytoskeletal structures and permanently altered (i.e., self-sustaining or epigenetic) transcription of target genes. A common theme is that genes whose transcription is elevated to the greatest extent by Ras often have in their promoters juxtaposed binding sites for two different transcription factors (particularly those in the Fos/Jun, CREB/ATF, NFκB, and Ets families) each of which is activated and such that together they synergize to augment transcription substantially. Some of these transcription factors can also act as oncogenes in certain cell types when appropriately modified and expressed. This unifying theme among many different cancers suggests that strategies to restore the balance among the signaling pathways or to suppress synergistic interactions between transcription factors may prove broadly useful in reversing the malignant phenotype.

によって引用された
  1. Kerkelä E., Saarialho-Kere U., Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer, Experimental Dermatology, 12, 2, 2003. Crossref

  2. Akhurst Rosemary J., Balmain Allan, Genetic events and the role of TGFβ in epithelial tumour progression, The Journal of Pathology, 187, 1, 1999. Crossref

  3. Stärkel Peter, Charette Nicolas, Borbath Ivan, Schneider-Merck Tanja, De Saeger Christine, Abarca Jorge, Leclercq Isabelle, Horsmans Yves, Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: Association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis, Molecular Carcinogenesis, 51, 10, 2012. Crossref

  4. Witt Ken A., Mark Karen S., Huber Jason, Davis Thomas P., Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress, Journal of Neurochemistry, 92, 1, 2005. Crossref

  5. Li Jian-Jian, Cao Ya, Young Mathew R., Colburn Nancy H., Induced expression of dominant-negative c-jun downregulates NF?B and AP-1 target genes and suppresses tumor phenotype in human keratinocytes, Molecular Carcinogenesis, 29, 3, 2000. Crossref

  6. Servotte S., Zhang Z., Lambert C. A., Giang Ho T. T., Chometon G., Eckes B., Krieg T., Lapière C. M., Nusgens B. V., Aumailley M., Establishment of stable human fibroblast cell lines constitutively expressing active Rho-GTPases, Protoplasma, 229, 2-4, 2006. Crossref

  7. Dai Jianxin, Li Bohua, Shi Jinping, Peng Ling, Zhang Dapeng, Qian Weizhu, Hou Sheng, Zhao Lei, Gao Jie, Cao Zhiguo, Zhao Jian, Wang Hao, Guo Yajun, A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo, Cancer Immunology, Immunotherapy, 59, 3, 2010. Crossref

  8. Piek Ester, Roberts Anita B., , 83, 2001. Crossref

  9. Nemoto Hiroyuki, Rittling Susan R., Yoshitake Hiroyuki, Furuya Koichi, Amagasa Teruo, Tsuji Kunikazu, Nifuji Akira, Denhardt David T., Noda Masaki, Osteopontin Deficiency Reduces Experimental Tumor Cell Metastasis to Bone and Soft Tissues, Journal of Bone and Mineral Research, 16, 4, 2001. Crossref

  10. Kumari Sangeeta, Saradhi Mallampati, Rana Manjul, Chatterjee Swagata, Aumercier Marc, Mukhopadhyay Gauranga, Tyagi Rakesh K., Pregnane and Xenobiotic Receptor gene expression in liver cells is modulated by Ets-1 in synchrony with transcription factors Pax5, LEF-1 and c-jun, Experimental Cell Research, 330, 2, 2015. Crossref

  11. Fu Z., Smith P. C., Zhang L., Rubin M. A., Dunn R. L., Yao Z., Keller E. T., Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis, JNCI Journal of the National Cancer Institute, 95, 12, 2003. Crossref

  12. Aftab Taiyab, Usha Kuppa Srinivas, Amere Subbarao Sreedhar, 17-(Allylamino)-17-Demethoxygeldanamycin Combination with Curcumin Selectively Targets Mitogen Kinase Pathway in A Human Neuroblastoma Cell Line, Journal of Cancer Therapy, 01, 04, 2010. Crossref

  13. Roberts Anita B., Piek Ester, Böttinger Erwin P., Ashcroft Gillian, Mitchell James B., Flanders Kathleen C., Is Smad3 a Major Player in Signal Transduction Pathways Leading to Fibrogenesis?, Chest, 120, 1, 2001. Crossref

  14. Weinstein-Oppenheimer Caroline R, Blalock William L, Steelman Linda S, Chang Fumin, McCubrey James A, The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors, Pharmacology & Therapeutics, 88, 3, 2000. Crossref

  15. Yu Kyeong-Nam, Minai-Tehrani Arash, Chang Seung-Hee, Hwang Soon-Kyung, Hong Seong-Ho, Kim Ji-Eun, Shin Ji-Young, Park Sung-Jin, Kim Ji-Hye, Kwon Jung-Taek, Jiang Hu-Lin, Kang Bitna, Kim Duyeol, Chae Chan-Hee, Lee Kee-Ho, Yoon Tae-Jong, Beck George R., Cho Myung-Haing, Aziz Syed A., Aerosol Delivery of Small Hairpin Osteopontin Blocks Pulmonary Metastasis of Breast Cancer in Mice, PLoS ONE, 5, 12, 2010. Crossref

  16. Zhang Michelle G., Lee John Y., Gallo Ryan A., Tao Wensi, Tse David, Doddapaneni Ravi, Pelaez Daniel, Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer, Pharmacological Research, 129, 2018. Crossref

  17. Xiao Zhi-Qiang, Majumdar Adhip P. N., Induction of transcriptional activity of AP-1 and NF-κB in the gastric mucosa during aging, American Journal of Physiology-Gastrointestinal and Liver Physiology, 278, 6, 2000. Crossref

  18. Li Jian-Jian, Oberley Larry W., Fan Ming, Colburn Nancy H., Inhibition of AP‐1 and NF‐κB by manganese‐containing superoxide dismutase in human breast cancer cells, The FASEB Journal, 12, 15, 1998. Crossref

  19. Subramani Ramadevi, Camacho Fernando A., Levin Carly Ivy, Flores Kristina, Clift Alexa, Galvez Adriana, Terres Mauricio, Rivera Servando, Kolli Sai Navana, Dodderer Joshua, Miranda Megan, Rodriguez Alejandro, Pedroza Diego A., Chatterjee Animesh, Lakshmanaswamy Rajkumar, FOXC1 plays a crucial role in the growth of pancreatic cancer, Oncogenesis, 7, 7, 2018. Crossref

  20. Coutinho Sunita, Jahn Thomas, Lewitzky Marc, Feller Stephan, Hutzler Peter, Peschel Christian, Duyster Justus, Characterization of Grb4, an adapter protein interacting with Bcr-Abl, Blood, 96, 2, 2000. Crossref

  21. Napolitano Giorgio, Montani Valeria, Giuliani Cesidio, Di Vincenzo Simonetta, Bucci Ines, Todisco Valentina, Laglia Giovanna, Coppa Anna, Singer Dinah S., Nakazato Minoru, Kohn Leonard D., Colletta Giulia, Monaco Fabrizio, Transforming Growth Factor-β1 Down-Regulation of Major Histocompatibility Complex Class I in Thyrocytes: Coordinate Regulation Of Two Separate Elements by Thyroid-Specific as Well as Ubiquitous Transcription Factors, Molecular Endocrinology, 14, 4, 2000. Crossref

  22. Coutinho Sunita, Jahn Thomas, Lewitzky Marc, Feller Stephan, Hutzler Peter, Peschel Christian, Duyster Justus, Characterization of Grb4, an adapter protein interacting with Bcr-Abl, Blood, 96, 2, 2000. Crossref

  23. Kohn Ethan A., Tang Binwu, Tumor Suppressor and Pro-progression Roles for TGF-β in Breast Cancer, in Transforming Growth Factor-β in Cancer Therapy, Volume II, 2008. Crossref

  24. Stelma Tamara, Leaner Virna D., KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells, Oncotarget, 8, 20, 2017. Crossref

  25. Wang Shiow Y., Feng Rentian, Bowman Linda, Penhallegon Ross, Ding Min, Lu Y., Antioxidant Activity in Lingonberries (Vaccinium vitis-idaea L.) and Its Inhibitory Effect on Activator Protein-1, Nuclear Factor-κB, and Mitogen-Activated Protein Kinases Activation, Journal of Agricultural and Food Chemistry, 53, 8, 2005. Crossref

  26. Wang Shiow Y., Feng Rentian, Lu Yongju, Bowman Linda, Ding Min, Inhibitory Effect on Activator Protein-1, Nuclear Factor-KappaB, and Cell Transformation by Extracts of Strawberries (Fragaria × ananassa Duch.), Journal of Agricultural and Food Chemistry, 53, 10, 2005. Crossref

  27. Wang XiaoHui, Ji Cheng, Zhang HongHan, Shan Yu, Ren YiJie, Hu YanWei, Shi LiangRong, Guo LingChuan, Zhu WeiDong, Xia YuJuan, Liu BeiJia, Rong ZiYun, Wu BiLian, Ming ZhiJun, Ren XingCong, Song JianXun, Yang JinMing, Zhang Yi, Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents, Journal of Biological Chemistry, 294, 25, 2019. Crossref

  28. Crawford Howard C., Fingleton Barbara, Gustavson Mark D., Kurpios Natasza, Wagenaar Rebecca A., Hassell John A., Matrisian Lynn M., The PEA3 Subfamily of Ets Transcription Factors Synergizes with β-Catenin–LEF-1 To Activate Matrilysin Transcription in Intestinal Tumors, Molecular and Cellular Biology, 21, 4, 2001. Crossref

  29. Dai J, Peng L, Fan K, Wang H, Wei R, Ji G, Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W, Guo Y, Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells, Oncogene, 28, 38, 2009. Crossref

  30. Kumar N. Vinay, Bernstein Lori R., Ten ERK-related Proteins in Three Distinct Classes Associate with AP-1 Proteins and/or AP-1 DNA, Journal of Biological Chemistry, 276, 34, 2001. Crossref

  31. Chen Li, Wang Xiaoyu, Fluck Michele M., Independent Contributions of Polyomavirus Middle T and Small T to the Regulation of Early and Late Gene Expression and DNA Replication, Journal of Virology, 80, 15, 2006. Crossref

  32. Johnston Imogen MP, Spence Heather J, Winnie Joseph N, McGarry Lynn, Vass J Keith, Meagher Liam, Stapleton Genevieve, Ozanne Bradford W, Regulation of a multigenic invasion programme by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion, Oncogene, 19, 47, 2000. Crossref

  33. Darnell James E., Transcription factors as targets for cancer therapy, Nature Reviews Cancer, 2, 10, 2002. Crossref

  34. Liu Yongmin, Borchert Gregory L., Phang James M., Polyoma Enhancer Activator 3, an Ets Transcription Factor, Mediates the Induction of Cyclooxygenase-2 by Nitric Oxide in Colorectal Cancer Cells, Journal of Biological Chemistry, 279, 18, 2004. Crossref

  35. Raghavendra P.B., Cancer biology and other disorders: beneficial role of camptothecin and novel derivatives, in Camptothecin and Camptothecin Producing Plants, 2020. Crossref

  36. Liu Guangming, Chen Nanyue, Kaji Akira, Bode Ann M., Ryan Clarence A., Dong Zigang, Proteinase inhibitors I and II from potatoes block UVB-induced AP-1 activity by regulating the AP-1 protein compositional patterns in JB6 cells, Proceedings of the National Academy of Sciences, 98, 10, 2001. Crossref

  37. Takeda Takayuki, Hattori Noboru, Tokuhara Takahiro, Nishimura Yoshihiro, Yokoyama Mitsuhiro, Miyake Masayuki, Adenoviral Transduction of MRP-1/CD9 and KAI1/CD82 Inhibits Lymph Node Metastasis in Orthotopic Lung Cancer Model, Cancer Research, 67, 4, 2007. Crossref

  38. Swamy Supritha G., Kameshwar Vivek H., Shubha Priya B., Looi Chung Yeng, Shanmugam Muthu K., Arfuso Frank, Dharmarajan Arunasalam, Sethi Gautam, Shivananju Nanjunda Swamy, Bishayee Anupam, Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma, Targeted Oncology, 12, 1, 2017. Crossref

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain